.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Julphar
Dow
Novartis
QuintilesIMS
Cantor Fitzgerald
Baxter
Fuji
Boehringer Ingelheim
Medtronic

Generated: November 22, 2017

DrugPatentWatch Database Preview

Claims for Patent: 4,158,055

« Back to Dashboard

Claims for Patent: 4,158,055

Title: Administration of 16.alpha.,17.alpha.-cyclopentylidenedioxy-9.alpha.-fluor O-11.beta.,21-dihydroxy-1,4-pregnadiene-3,20-dione 21-acetate
Abstract:A method of treating topical inflammation in mammals by the administration of 16.alpha.,17.alpha.-cyclopentylidenedioxy-9.alpha.-fluoro-11.beta.,21-dihy droxy-1,4-pregnadiene-3,20-dione 21-acetate in a pharmaceutically acceptable carrier.
Inventor(s): Shultz; Walter (Spring Valley, NY), Sieger; George M. (Montvale, NJ), Krieger; Charles (Clifton, NJ)
Assignee: American Cyanamid Company (Stamford, CT)
Application Number:05/754,917
Patent Claims: 1. A method of ameliorating inflammation in a mammal which comprises administering topically to said mammal an anti-inflammatory effective amount of 16.alpha.,17.alpha.-cyclopentylidenedioxy-9.alpha.-fluoro-11.beta.,21-dihy droxy-1,4-pregnadiene-3,20-dione 21-acetate in association with a topical pharmaceutically acceptable carrier.

2. A method in accordance with claim 1, wherein the anti-inflammatory agent is incorporated in a topical cream.

3. A method in accordance with claim 1, wherein the anti-inflammatory agent is incorporated in a topical ointment.

4. A method in accordance with claim 1, wherein the anti-inflammatory agent is incorporated in a topical foam.

5. A method in accordance with claim 1, wherein the anti-inflammatory agent is incorporated in an ophthalmic ointment.

6. A method in accordance with claim 1, wherein the anti-inflammatory agent is incorporated in a topical lotion.

7. A method of treating inflammation in a mammal comprising administering topically to said mammal an anti-inflammatory effective amount of the steroid, 16.alpha.,17.alpha.-cyclopentylidenedioxy-9.alpha.-fluoro-11.beta.,21-dihy droxy-1,4-pregnadiene-3,20-dione 21-acetate in association with a topical pharmaceutically acceptable carrier in which the steroid is present in a concentration range of from about 0.01% to about 0.50%.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Johnson and Johnson
Baxter
Deloitte
Federal Trade Commission
Chinese Patent Office
Daiichi Sankyo
Accenture
AstraZeneca
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot